StonvexLoading…
StonvexStonvexStonvexCore line items from DCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Annual 2025 2025-09-27 | Annual 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $209.02M | $824.84M | $607.71M | $393.28M |
Operating Income | $15.72M | $-35.73M | $-52.62M | $22.70M |
Net Income | $9.92M | $-37.35M | $-46.67M | $14.16M |
EPS (Diluted) | $0.64 | $-2.50 | $-3.13 | $0.93 |
Total Assets | $1.19B | $1.19B | $1.25B | $1.14B |
Total Liabilities | $515.54M | $524.93M | $601.08M | $433.33M |
Cash & Equivalents | $39.10M | $45.29M | $50.92M | $37.12M |
Free Cash Flow OCF − CapEx | $8.30M | $-48.64M | $30.11M | $14.10M |
Shares Outstanding | 15.08M | 14.95M | 14.95M | 14.92M |